Innovation Pharmaceuticals Inc.

IPIXOTC Markets OTCPK·Healthcare

$0.00▲ +0.00 (+0.00%)

Market closedData as of 10:24 PM ET · 15-min delay

Analyst ratingnone

Every calculator, already run for IPIX

What is it worth?

P/E calculatorHow does this multiple compare to peers and its own history?Run →DCF calculatorTen years of free cash flow, discounted back to today.Run →Reverse DCFSolves the price backwards for the growth it already requires.Run →EV / EBITDAThe price with debt added and cash netted off.-0.1x PEG ratioThe multiple divided by the growth meant to justify it.Run →Graham numberGraham's ceiling from earnings and book value.Run →P/S ratioFor companies whose earnings are not the point yet.Run →Intrinsic valueDCF, multiples and Graham run together as one range.Run →

Is it any good?

ROIC calculatorWhether a dollar invested earns more than it costs.-334.8%Altman Z-scoreFive balance-sheet ratios weighted into a distress score.-25.21 · distress Piotroski F-scoreNine pass-fail tests on profit, leverage and efficiency.2 of 6 Debt to equityHow much of the balance sheet is borrowed.0.10 Interest coverageHow many times operating profit covers the interest bill.55x Profit marginGross, operating and net, each against the sector.0.0% net Free cash flowOperating cash after the capex needed to keep going.-$986k Rule of 40Revenue growth plus margin, the software health line.

What does it return & pay?

ROE calculatorProfit against the equity shareholders left in.-114.3%EPS growthEarnings per share compounded over the filings.Run →CAGR calculatorCompound rate on revenue, earnings, cash or price.Run →Dividend yieldWhat it pays, and whether free cash flow covers it.0.00%Net payout yieldDividends plus buybacks, less shares issued.27.7%Owner earningsBuffett's version: cash a buyer could actually take out.-$2M

You have the numbers on IPIX. Get the argument.

A written report on which of these readings actually decide the outcome for Innovation Pharmaceuticals Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.

Key market data

Market cap$311,008

P/E (TTM)—

Forward P/E—

Beta153.16

EPS (TTM)$-0.01

Dividend yield—

Volume12.6K

Avg volume116.4K

52-week range

$0.00$0.05

About Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and i…

HealthcareBiotechnology4 employeesUnited States

IPIX — frequently asked

Is IPIX a buy right now?

Wall Street's consensus rating on Innovation Pharmaceuticals Inc. is none. Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.

Compare Innovation Pharmaceuticals Inc. against related stocks

Explore additional stock overview pages and jump directly into full report generation for each symbol.

Sector peers

Most-followed names in the same sector.

LLY stock overview UNH stock overview JNJ stock overview MRK stock overview ABBV stock overview PFE stock overview AMGN stock overview ISRG stock overview

Nearby tickers

Additional public equities from our tracked universe.

IPG stock overview IPAR stock overview IPWR stock overview IP stock overview IQV stock overview IONQ stock overview IR stock overview

Market leaders

Large-cap symbols investors frequently compare.

AAPL stock overview MSFT stock overview NVDA stock overview AMZN stock overview GOOGL stock overview META stock overview TSLA stock overview JPM stock overview

Investor Guides For Innovation Pharmaceuticals Inc.

Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.

Equity Research ChecklistsThe healthcare diligence checklist worth running before you size anything Earnings Question BanksThe healthcare earnings questions that matter after the headline beat Valuation PlaybooksWhat deserves the multiple in healthcare Red Flag WatchlistsThe healthcare red flags that quietly wreck the thesis

Generate your full IPIX research report

DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Innovation Pharmaceuticals Inc., in minutes. 3 free reports included with every account — no credit card required.